RÉSUMÉ
The outbreak of histamine fish poisoning has been being an issue in food safety and international trade. The growth of contaminated bacterial species including Morganella morganii which produce histidine decarboxylase causes histamine formation in fish during storage. Histamine, the main toxin, causes mild to severe allergic reaction. At present, there is no well-established solution for histamine fish poisoning. This study was performed to determine the antibacterial activity of essential oils from Thai spices against histamine-producing bacteria. Among the essential oils tested, clove, lemongrass and sweet basil oils were found to possess the antibacterial activity. Clove oil showed the strongest inhibitory activity against Morganella morganii, followed by lemongrass and sweet basil oils. The results indicated that clove, lemongrass and sweet basil oils could be useful for the control of histamine-producing bacteria. The attempt to identify the active components using preparative TLC and GC/MS found eugenol, citral and methyl chavicol as the active components of clove, lemongrass and sweet basil oils, respectively. The information from this study would be useful in the research and development for the control of histamine-producing bacteria in fish or seafood products to reduce the incidence of histamine fish poisoning
Sujet(s)
Histamine/biosynthèse , Histidine decarboxylase/métabolisme , Antibactériens/isolement et purification , Morganella morganii/effets des médicaments et des substances chimiques , Zingiberaceae/composition chimique , Tests de sensibilité microbienne , Cymbopogon/composition chimique , Eugenia/composition chimique , Huile essentielle/isolement et purificationRÉSUMÉ
BACKGROUND: Rat mast cells were regarded as a good model for mast cell function in immune response. METHODS: Rat bone marrow mast cells (BMMC) were prepared both by recombinant rat IL-3 (rrIL-3) and by recombinant mouse stem cell factor (rmSCF), and investigated for both proliferation and differentiation in time course. Rat BMMC was induced by culture of rat bone marrow cells (BMCs) in the presence of both rrIL-3 (5 ng/ml) and rmSCF (5 ng/ml). Culture media were changed 2 times per week with the cell number condition of 5x10(4)/ml in 6 well plate. Proliferation was analyzed by cell number and cell counting kit-8 (CCK-8) and differentiation was by rat mast cell protease (RMCP) II and histamine. RESULTS: Cell proliferation rates reached a maximum at 8 or 11 days of culture and decreased thereafter. However, both RMCP II production and histamine synthesis peaked after 11 days of culture. By real time RT-PCR, the level of histidine decarboxylase mRNA was more than 500 times higher on culture day 11 than on culture day 5. By transmission electron microscopy, the cells were heterogeneous in size and contained cytoplasmic granules. Using gated flow cytometry, we showed that cultured BMCs expressed high levels of FcepsilonRI and the mast cell antigen, ganglioside, on culture day 11. CONCLUSION: These results indicate that rat BMMCs were generated by culturing BMCs in the presence of rrIL-3 and rmSCF and that the BMMCs have the characteristics of mucosal mast cells.
Sujet(s)
Animaux , Souris , Rats , Moelle osseuse , Cellules de la moelle osseuse , Numération cellulaire , Prolifération cellulaire , Milieux de culture , Granulations cytoplasmiques , Cytométrie en flux , Histamine , Histidine decarboxylase , Interleukine-3 , Cinétique , Mastocytes , Microscopie électronique à transmission , Phénotype , ARN messager , Facteur de croissance des cellules souchesRÉSUMÉ
<p><b>OBJECTIVE</b>To investigate the modulatory effects of morphine on the susceptibility to pentylenetetrazole-induced seizures, and the involvement of endogenous histamine in this process.</p><p><b>METHODS</b>Both the wild-type (WT) mice and histidine decarboxylase (a key enzyme for histamine biosynthesis) deficient (HDC-KO) mice were subcutaneously injected with different doses of morphine, and 1 hour later the pentylenetetrazole solution (1.5 %) was infused into the tail vein at a constant rate of 0.3 ml/min. The minimal dose of pentylenetetrazole (mg/kg) needed to induce myoclonic jerks and clonus convulsion was recorded as the thresholds of seizures.</p><p><b>RESULT</b>In WT mice, morphine dose-dependently decreased the thresholds of both myoclonic jerks and clonus convulsion. In HDC-KO mice, morphine at 10 mg/kg only significantly decreased the threshold of myoclonic jerks from (38.6 +/-2.9)mg/kg to (32.5 +/-0.7)mg/kg, but had no significant effect on the threshold of clonus convulsion [from (51.8 +/-2.1)mg/kg to (47.6 +/-1.2)mg/kg]. In addition, the value of decreased myoclonic jerks (15.8 +/-1.4)% and clonus convulsion (8.3 +/-0.9)% thresholds were much lower in HDC-KO mice than in WT mice [(26.1 +/-2.5)% and (20.8 +/-2.4)%, respectively].</p><p><b>CONCLUSION</b>Morphine can decrease the thresholds of pentylenetetrazole in induction of seizure, and the endogenous histamine may be involved in this process.</p>
Sujet(s)
Animaux , Mâle , Souris , Prédisposition aux maladies , Métabolisme , Relation dose-effet des médicaments , Histamine , Métabolisme , Physiologie , Histidine decarboxylase , Génétique , Métabolisme , Souris knockout , Morphine , Pharmacologie , Myoclonie , Métabolisme , Stupéfiants , Pharmacologie , Pentétrazol , Répartition aléatoire , Crises épileptiques , Génétique , Seuils sensorielsRÉSUMÉ
Effects of some drugs modulating central histaminergic (HA) transmission were evaluated on restraint stress (RS)-induced gastric ulcerogenesis, plasma corticosterone and immune responses in rats. RS for (i) 6 hr or (ii) 24 hr at room temperature, and (iii) 3 hr at 4 degrees C (CRS) all induced gastric mucosal erosions and elevated plasma corticosterone levels, the effects with the latter two RS procedures being most consistent. Pretreatment of rats with neuronal HA depletor, alpha-FMH (100 mg/kg, ip) attenuated both ulcer severity and corticosterone response, during both 24 hr RS and CRS. Similar effects were also seen with the mast cell degranulator, C-48/80 (10 micrograms/kg, i.c.v.) treatment. Further, the H1-blocker, pheniramine (25 mg/kg, ip) but not the centrally acting H2-blocker, zolantidine (5 mg/kg, ip) produced clearcut attenuations in both stress markers, during the experimental stressors. In rats immunized in SRBC, 24 hr RS (and not CRS) significantly prevented the humoral immune responses to the antigen. alpha-FMH, C 48/80 and pheniramine but not zolantidine, reversed this response during 24 hr RS. The results indicate a central HA ergic involvement in the visceral, endocrinal and immune responses during RS and suggest the probable role of both neuronal as well as extraneuronal (mast cell) HA and activation of H1-receptors in the mediation of these effects.
Sujet(s)
Animaux , Production d'anticorps/effets des médicaments et des substances chimiques , Benzothiazoles , Encéphale/métabolisme , Corticostérone/sang , Histamine/physiologie , Antihistaminiques des récepteurs H2/pharmacologie , Histidine decarboxylase/antagonistes et inhibiteurs , Mâle , Méthylhistidines/pharmacologie , Ulcère peptique/étiologie , Phéniramine/pharmacologie , Phénoxypropanolamines , Pipéridines/pharmacologie , Rats , Rat Wistar , Stress physiologique/complications , Thiazoles/pharmacologieSujet(s)
Rats , Animaux , Femelle , Tumeurs du sein , Lévamisole/pharmacocinétique , Adénocarcinome , Hormone folliculostimulante/sang , Histamine/biosynthèse , Histidine decarboxylase/immunologie , Lévamisole/immunologie , Lévamisole/usage thérapeutique , Hormone lutéinisante/sang , 1-Méthyl-1-nitroso-urée/effets indésirables , Progestérone/sang , Prolactine/sangRÉSUMÉ
Adenocarcinomas mamarios fueron inducidos en ratas Sprague-Dawley mediante N-nitraso-N-metil-urea (NMV). Una vez que el primer tumor se hacía evidente, los animales fueron tratados diariamente con una dosis oral de 4 mg/kg de animal de Levamisol (Leva). La actividad de histidina decarboxilasa (HDC), expresada dpm/(g,h), se determinó en el tumor y en el intestino con C-histidina por medición de actividad de CO2 con espectrometría de centelleo líquido. La histopatología demostró que todos los tumores inducidos eran adenocarcinomas mamarios más o menos diferenciados. Como fuera observado en otros casos, la actividad de HDC tumoral fue alta comparada con la de tejidos normales. El tratamiento con Leva durante 7 y 14 días no produjo influencias significativas sobre la actividad de HDC, si bien se evidenció una disminución de la actividad enzimática. La administración de Leva durante más de 20 días provocó una disminución significativa de la actividad de HDC. La actividad de dicha enzima dependió, en todos los casos, de la masa total del tumor (MTT). La actividad de HDC en función de MTT es una función lineal con coeficientes de correlación superiores a 0,9. Para las ratas tratadas con Leva durante 20 días o más, la pedndiente fue de 1,93 ñ 0,89. Para animales no tratados, la pendiente fue de 7,37 ñ 1,23. La diferencia es estadisticamente significativa de acuerdo al criterio de la distribución F (P <0,001). Nuestros resultados demuestran que un agente inmunomodulador exhibe un definido tiempo de retraso antes de ejercer su influencia sobre el metbolismo de la histamina, el cual anormal en diferentes tipos de tumores. En trabajos futuros se estudiará si este efecto está relacionado con la acción inmunomoduladora de la droga